Jan 12, 2024 · However, biotechnology remains a profitable investment in the long term. Over the past five years, the market cap for the top 25 biotechnology companies soared nearly 78% from the combined $963. ...

Aug 23, 2024 · This year, GEN’s list of top 10 contract development and manufacturing organizations is led by Lonza, which works across five continents and relies on a global community of around 18,000 ...

Get the latest news and information on genetic engineering and biotechnology including analysis, features, webinars, podcasts, and more.

Feb 1, 2024 · Viewed simply by numbers of merger and acquisition (M&A) deals, 2023 was a down year: 1,078 biotech companies found buyers last year, down from 1,088 in 2022, while the number of pharma companies ...

Sep 15, 2023 · GEN’s first-ever Top 10 A-List of contract developers and manufacturers is here. Of the top 10 companies listed, only three are headquartered in the U.S.; the rest are based in China, Germany ...

Oct 16, 2024 · Pfizer will apply Triana Biomedicines’ target-first and proximity-first discovery platform to discover molecular glue degraders for unspecified “multiple” targets in oncology and several ...

Aug 8, 2024 · Two months earlier, Exscientia pruned its pipeline down to four active drug candidates in therapeutic areas that include inflammatory disease, hematology, and most notably, oncology.. The value of ...

Oct 17, 2024 · Analyzing the purity of adeno-associated virus (AAV)-based gene therapy products requires effective methods for detecting host proteins, DNA, and incomplete viral particles in samples.

May 8, 2024 · Pfizer has paused enrollment in a Phase III trial assessing its Duchenne muscular dystrophy (DMD) gene therapy candidate fordadistrogene movaparvovec after acknowledging the sudden death of a ...

Nov 21, 2024 · Novartis has acquired Kate Therapeutics for up to $1.1 billion, the companies said today, in a deal that expands the buyer’s presence in both neuroscience drug development and gene therapy.